NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

14 hedge funds and large institutions have $2.27M invested in NeuBase Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$435K
2 +$140K
3 +$88K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$66.1K
5
Morgan Stanley
Morgan Stanley
New York
+$21K

Top Sellers

1 -$97.6K
2 -$87K
3 -$47K
4
First Manhattan
First Manhattan
New York
-$13K
5
Deutsche Bank
Deutsche Bank
Germany
-$11K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.07M
2
$529K
3
$214K
4
$140K
5
$89K
6
$88K
7
$47K
8
$24K
9
$21K
10
$15K
11
$11K
12
$11K
13
$9K
14
$3K
15
16